KROS NASDAQ
Keros Therapeutics, Inc.
1W: -2.2%
1M: +1.2%
3M: +3.0%
YTD: -38.7%
1Y: -25.6%
3Y: -64.5%
5Y: -65.6%
$11.36
+0.10 (+0.89%)
Weekly Expected Move ±4.8%
$10
$11
$11
$12
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$15M
Revenue
-93.6% YoY
$-83M
Net Income
-543.0% YoY
$-48M
Free Cash Flow
-191.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-17.2%
ROA-15.9%
ROIC-392.2%
Valuation
P/E-3.1
P/B0.9
EV/EBITDA0.4
Leverage
Debt/Equity0.06
Current Ratio21.96
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z2.56
Beneish M0.00